Megan Doyle is an attorney who spent more than 10 years advising on matters pertaining to the regulation of drugs, medical devices, combination products, and in vitro diagnostics. After seven years in the medical device practice at Hogan Lovells, she joined Amgen as a Senior Counsel for Health Regulatory. For four years, she counseled Amgen on drug, device, combination product, and diagnostic matters. Currently, she is a Director in Amgen’s Global Regulatory and R&D Policy group, where she is the Global Policy Lead for Diagnostics, Digital Health, and Combination Products.
Sessions
P2: Optimizing Regulatory Outcomes in the Current Environment through Addressing New...
P2: Q&A for Optimizing Regulatory Outcomes in the Current Environment through Addressing New...